Etrolizumab (RG7413) - IBD News Today
Etrolizumab (RG7413) is a monoclonal antibody, now in Phase 3 tests, being developed by Genentech to treat both ulcerative colitis and Crohn’s disease.
Source: ibdnewstoday.com
Retro Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Retro Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Retro Studies Today - Breaking & Trending Today